Skip to main content
. 2014 Mar 7;14:29. doi: 10.1186/1471-2318-14-29

Table 4.

Results of logistic regression models

  Unadjusted model Model 1 Model 2 Model 3
Hemoglobin-level (continuous, per SD decrease)
Total sample
1.36 (1.14-1.64)
1.13 (0.92-1.38)
1.11 (0.90-1.37)
1.09 (0.89-1.34)
Age 65-74
1.25 (0.91-1.73)
1.12 (0.78-1.61)
1.09 (0.75-1.57)
1.10 (0.76-1.59)
Age >74
1.35 (1.09-1.69)
1.23 (0.97-1.57)
1.21 (0.94-1.55)
1.15 (0.89-1.48)
Men
1.25 (0.94-1.65)
1.15 (0.87-1.54)
1.14 (0.85-1.55)
1.11 (0.83-1.49)
Age 65-74
0.98 (0.60-1.62)
 
1.00 (0.60-1.66)
1.00 (0.60-1.66)
Age >74
1.33 (0.94-1.87)
 
1.29 (0.89-1.85)
1.19 (0.83-1.73)
Women
1.25 (0.95-1.64)
1.11 (0.83-1.47)
1.09 (0.81-1.45)
1.07 (0.80-1.43)
Age 65-74
1.28 (0.77-2.13)
 
1.21 (0.72-2.03)
1.22 (0.72-2.06)
Age >74
1.15 (0.83-1.61)
 
1.14 (0.81-1.60)
1.09 (0.76-1.54)
Anemia definition according WHO [12]
Total sample
1.35 (0.87-2.09)
1.18 (0.75-1.86)
1.13 (0.71-1.80)
1.06 (0.66-1.70)
Age 65-74
1.24 (0.50-3.12)
1.23 (0.49-3.09)
1.17 (0.46-2.97)
1.21 (0.47-3.09)
Age >74
1.24 (0.74-2.05)
1.35 (0.81-2.26)
1.29 (0.76-2.19)
1.12 (0.65-1.92)
Men
1.79 (0.94-3.41)
1.51 (0.78-2.95)
1.49 (0.75-2.97)
1.35 (0.67-2.71)
Age 65-74
1.13 (0.24-5.30)
 
1.18 (0.25-5.61)
1.18 (0.24-5.90)
Age >74
1.85 (0.88-3.91)
 
1.73 (0.79-3.78)
1.50 (0.68-3.32)
Women
1.18 (0.65-2.17)
0.96 (0.52-1.80)
0.92 (0.49-1.74)
0.87 (0.46-1.66)
Age 65-74
1.29 (0.41-4.09)
 
1.20 (0.37-3.85)
1.22 (0.38-3.94)
Age >74
1.03 (0.50-2.11)
 
1.00 (0.48-2.08)
0.86 (0.40-1.81)
Joint analyses (total sample)
Anemic & frail
1.82 (1.05-3.15)
1.32 (0.74-2.38)
1.27 (0.70-2.30)
 
Anemic & not frail
1.51 (0.73-3.14)
1.54 (0.73-3.25)
1.49 (0.70-3.16)
 
Not anemic & frail
1.76 (1.17-2.63)
1.40 (0.91-2.15)
1.38 (0.90-2.13)
 
Not anemic & not frail
1.00
1.00
1.00
 
Anemic & disabled
2.99 (1.69-5.29)
2.17 (1.18-3.99)
2.10 (1.12-3.93)
 
Anemic & not disabled
0.94 (0.48-1.84)
0.87 (0.44-1.72)
0.85 (0.43-1.70)
 
Not anemic & disabled
2.32 (1.50-3.58)
1.64 (1.03-2.61)
1.61 (1.00-2.58)
 
Not anemic & not disabled 1.00 1.00 1.00  

Model 1: adjusted for age (in years, only in the whole sample and in sex-stratified analyses) and sex (only in the whole sample and in the age-stratified analyses).

Model 2: in addition to model 1 adjusted for number of drugs.

Model 3: in addition to model 2 adjusted for disability.

Significant results are written in bold.